Vnus endovenous laser ablation settlement
This article was originally published in The Gray Sheet
Executive Summary
AngioDynamics and Vascular Solutions gain non-exclusive licenses to Vnus Medical patents relating to disposable endovenous laser fiber kits, laser fibers and lasers used for endovenous laser ablation, in exchange for upfront payments of $6.8 million and $3.1 million, respectively, under a settlement of 2005 patent litigation, announced June 3. The license also requires ongoing royalty payments until September 2017 ("1The Gray Sheet" Oct. 8, 2007, In Brief)